Efficacy and tolerability of interferon-free antiviral therapy in kidney transplant recipients with chronic hepatitis C-Reference-Cited by-同舟云学术

Efficacy and tolerability of interferon-free antiviral therapy in kidney transplant recipients with chronic hepatitis C

Published:2017-04 Issue:4 Volume:66 Page:718-723
ISSN:0168-8278
Container-title:Journal of Hepatology
language:en
Short-container-title:Journal of Hepatology

Author:

Fernández Inmaculada,Muñoz-Gómez Raquel,Pascasio Juan M.,Baliellas Carme,Polanco Natalia,Esforzado Nuria,Arias Ana,Prieto Martín,Castells Lluis,Cuervas-Mons Valentín,Hernández Olga,Crespo Javier,Calleja José L.,Forns Xavier,Londoño María-Carlota

Publisher

Elsevier BV

Subject

Hepatology

Reference19 articles.

1. Hepatitis C and its impact on renal transplantation;Morales;Nat Rev Nephrol,2015

2. Hepatitis C virus infection increases the risk of developing chronic kidney disease: a systematic review and meta-analysis;Fabrizi;Dig Dis Sci,2015

3. Hepatitis C virus infection in chronic kidney disease;Ladino;J Am Soc Nephrol,2016

4. Treatment of hepatitis C after kidney transplant: a pooled analysis of observational studies;Fabrizi;J Med Virol,2014

5. Guideline 4: Management of HCV-infected patients before and after kidney transplantation

Cited by 88 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Efficacy and Safety of Sofosbuvir and Ledipasvir for Hepatitis C in Kidney Transplant Recipients: A Single-center Retrospective Observational Study;Balkan Medical Journal;2023-05-10

2. KDIGO 2022 Clinical Practice Guideline for the Prevention, Diagnosis, Evaluation, and Treatment of Hepatitis C in Chronic Kidney Disease;Kidney International;2022-12

3. Clinical perspectives towards improving risk stratification strategy for renal transplantation outcomes in Indian patients;Indian Journal of Transplantation;2022

4. Adjuvant use of ribavirin with treatment of hepatitis C virus in kidney transplant recipients: A systematic review and meta-analysis of real-world data;Indian Journal of Transplantation;2022

5. ‘Real-life’ experience with direct-acting antiviral agents for HCV after kidney transplant;Annals of Hepatology;2021-11